Check-in with us every morning as we kick off 90 minutes of Non-Stop ’90s at 8:00 am! @Totally939Miami! - #MackInTheMorning @MACKONTHERADIO & @iAmLettyB
Pfizer and BioNTech’s Covid vaccine is safe and appears to generate a robust immune response in a clinical trial of kids 5 to 11, the drugmakers announced. The companies tested a two-dose regimen of 10 micrograms — about a third the dosage used for teens and adults — administered three weeks apart. They plan to submit the data to the FDA and other health regulators “as soon as possible.”
"Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine. We are eager to extend the protection afforded by the vaccine to this younger population, subject to regulatory authorization, especially as we track the spread of the Delta variant and the substantial threat it poses to children," said Pfizer CEO Albert Bourla.